Four-Gene Signature Predicts Aggressive Prostate CancerFebruary 17th 2011
In a study reported in Nature online on February 2, researchers describe a four-gene signature that was more accurate than the standard Gleason score test in predicting which patients would die from metastatic spread of their prostate cancer.
Falls Are Key in Patient Assessment and PlanningFebruary 16th 2011
Falls and the risk of falls are critical health concerns that can impact cancer treatment and recovery. In 2007, the Centers for Disease Control (CDC) reported that more than 18,000 older adults in the United States died from injuries sustained from falls (CDC, 2010). Older people diagnosed with a malignancy and who are undergoing cancer treatment using chemotherapy have an increased risk of falls.
It is my pleasure to start 2011 by adding a new professional responsibility to my résumé, that of Editor-in-Chief of ONCOLOGY Nurse Edition. Although ONCOLOGY Nurse Edition is a relatively new publication, now entering its fifth year, the journal boasts a readership of 15,000 oncology nurses nationwide.
Fall Risk Assessment and PreventionFebruary 16th 2011
Patient falls are a common cause of morbidity and are the leading cause of injury deaths in adults age 65 years and older. Injuries sustained as result of falls in a cancer hospital are often severe, regardless of patient age, due to the nature of the underlying cancer.
Care of the Older Adult With CancerFebruary 16th 2011
One area in which to start is to ensure that colleagues are aware of the 2007 Oncology Nursing Society (ONS) Position Paper on cancer in the elderly. This position paper lays out the landscape of caring for older adults with cancer both in terms of problems to date and future initiatives to address.
Yoga, an ancient tradition that originated approximately 5,000 years ago in Central Asia, is a complete system of mental and physical practices for health and well-being. Predominantly practiced within the philosophical context of Ayurvedic medicine in India, yoga as a mind-body therapy is now also increasingly popular in the West, practiced by approximately 15 million individuals.
Cabazitaxel, a Taxane for Men With Hormone-Refractory Metastatic Prostate CancerOctober 19th 2010
Cabazitaxel is a microtubule inhibitor in the taxane class. It is made from a yew needle precursor using a semisynthetic process. It binds to free tubulin, which is used during mitosis to form two daughter cells.